ACTRN12616001215415招募中4 期
The evaluation of pre-exposure prophylaxis expanded across 2600 individuals at risk of HIV infection in Victoria, Australia.
The Alfred0 个研究点目标入组 2,600 人开始时间: 2016年9月2日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 2,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Age greater than or equal to 18 years old
- •Willing and able to provide informed consent
- •Documentation of an HIV negative test performed at enrolment
- •Have a creatinine clearance of > 60mL per minute eGFR
- •Will to provide an email address
- •Have a high risk of HIV infection as per the Australian PrEP Guidelines
排除标准
- •HIV infection confirmed by HIV antibody and western blot testing
- •Signs and symptoms of acute HIV infection
- •Unwilling to provide consent for follow up
- •An eGFR of <60 Mls per minute
- •Ues of any investigational agents which may interact or affect PrEP medication
- •use of any nephrotoxic agents
- •Concomitant participation in another clinical trial using investigational agents, including placebo-controlled agents
- •At enrolment an individual that has any other condition that, based on the opinion of the treating physician, would make participation in the project unsafe
研究者
相似试验
已完成
不适用
ncontrolled study of post-exposure prophylaxis for influenza by peramivirPatients exposed to influenzaJPRN-UMIN000014519Hokkaido University Hospital, Infection Control Team10
已完成
1 期
A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese MenHIV InfectionsNCT03422172ViiV Healthcare48
尚未招募
4 期
The effectiveness of HIV preventive methods in Brazilian health serviceC02.782.815.616.400HIV InfectionsRBR-2qfjpvDepartamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo
已完成
1 期
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, AfricaHIV InfectionNCT00931346International AIDS Vaccine Initiative72
Unknown
不适用
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.HIVNCT01989611Oswaldo Cruz Foundation400